Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound

Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound

US Patent 10130658 · Granted Nov 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref2025
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref2025
Tumor-infiltrating lymphocytes for adoptive cell therapy2025
Tumor-infiltrating lymphocytes for adoptive cell therapy2025
Tumor-infiltrating lymphocytes for adoptive cell therapy2025
Polypeptides and compositions comprising the same2025
Androgen receptor binding molecule and use thereof2024
Halogenated xanthene composition and method for treating hematologic cancers2024
Biomarkers for graft-versus-host disease2024
Composition and method for oral treatment of leukemia2024
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref2024
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref2024